Valuation: Byotrol plc

Market Cap 194K 261K 227K 211K 366K 24.9M 372K 2.49M 976K 12.39M 979K 958K 41.56M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.14M 989K 920K 1.6M 109M 1.62M 10.85M 4.26M 54.04M 4.27M 4.18M 181M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 2024-06-30
Director TitleAgeSince
Director/Board Member 50 2021-12-12
Chairman 75 2024-04-21
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
+0.37%-1.98%-3.97%-7.56% 336B
-2.21%+3.66%-4.36%+0.60% 137B
-0.33%+0.61%+8.88%+19.72% 73.06B
-0.31%-2.04%-16.65%-17.94% 51.72B
-0.36%-0.21%-10.26%-18.75% 36.94B
-1.15%+4.50%-10.11%-53.39% 30.35B
-0.07%+4.10%-25.94%-31.48% 20.29B
-0.14%+0.33%+14.78%+6.25% 19.7B
-3.43%+1.40%-4.02%+20.99% 18.55B
Average -2.76%+1.14%-5.74%-9.06% 80.51B
Weighted average by Cap. -0.46%-0.00%-4.34%-6.05%

Financials

2023 2024
Net sales 4.59M 6.18M 5.37M 5M 8.67M 590M 8.81M 58.95M 23.14M 294M 23.21M 22.7M 985M 3.97M 5.34M 4.65M 4.32M 7.5M 510M 7.61M 50.97M 20M 254M 20.07M 19.63M 852M
Net income -1.69M -2.28M -1.98M -1.84M -3.2M -217M -3.24M -21.72M -8.53M -108M -8.55M -8.37M -363M -3.06M -4.12M -3.59M -3.34M -5.79M -394M -5.88M -39.34M -15.44M -196M -15.49M -15.15M -657M
Net Debt 287K 386K 336K 313K 542K 36.88M 550K 3.68M 1.45M 18.36M 1.45M 1.42M 61.57M 651K 876K 762K 709K 1.23M 83.65M 1.25M 8.36M 3.28M 41.65M 3.29M 3.22M 140M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35